Upgrade to SI Premium - Free Trial

Nurix Therapeutics (NRIX)

15.30 -0.34 (2.17%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/9/26)

Latest Headlines

UBS Reiterates Buy Rating on Nurix (NRIX) June 9, 2026 9:30 AM - StreetInsider Nurix (NRIX) PT Raised to $32 at Truist Securities June 9, 2026 7:06 AM - StreetInsider Nurix (NRIX) PT Raised to $45 at Jefferies June 8, 2026 1:21 PM - StreetInsider Nurix (NRIX) PT Raised to $45 at Jefferies June 8, 2026 1:21 PM - StreetInsider Oppenheimer on Nurix (NRIX): 'A Big Check for a Big Opportunity' June 8, 2026 10:48 AM - StreetInsider Nurix (NRIX) trades up 20%, RBC says agreement with Roche removes some overhangs, 'We remain buyers' June 8, 2026 9:42 AM - StreetInsider Form 8-K Nurix Therapeutics, Inc. For: Jun 06 June 8, 2026 6:11 AM - SEC Filing Nurix Therapeutics partners with Roche on BTK degrader drug deal June 8, 2026 2:54 AM - StreetInsider Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology June 8, 2026 1:00 AM - Globe NewsWire Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology June 8, 2026 1:00 AM - StreetInsider Form 4 Nurix Therapeutics, Inc. For: Jun 02 Filed by: Ring Christine June 2, 2026 7:14 PM - SEC Filing Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine June 2, 2026 4:34 PM - SEC Filing BTIG Reiterates Buy Rating on Nurix (NRIX) May 18, 2026 6:07 AM - StreetInsider Form 4 Nurix Therapeutics, Inc. For: May 15 Filed by: Silva Paul M May 15, 2026 5:57 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: May 15 Filed by: Saltzman Edward C May 15, 2026 5:56 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: May 15 Filed by: Reinsdorf Judith A May 15, 2026 5:53 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: May 15 Filed by: Lacey David L. May 15, 2026 5:52 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: May 15 Filed by: Kapur Anil May 15, 2026 5:49 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: May 15 Filed by: DANSEY ROGER D May 15, 2026 5:46 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: May 15 Filed by: Baynes Roy D. May 15, 2026 5:42 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: May 15 Filed by: GREGORY JULIA P May 15, 2026 5:37 PM - SEC Filing Form SCHEDULE 13G Nurix Therapeutics, Inc. Filed by: Vestal Point Capital, LP May 15, 2026 5:06 PM - SEC Filing Form 8-K Nurix Therapeutics, Inc. For: May 15 May 15, 2026 4:05 PM - SEC Filing Form SCHEDULE 13G/A Nurix Therapeutics, Inc. Filed by: Deep Track Capital, LP May 15, 2026 8:46 AM - SEC Filing Nurix presents data on bexobrutideg for chronic urticaria at dermatology meeting May 14, 2026 4:05 PM - StreetInsider Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual M May 14, 2026 4:05 PM - Globe NewsWire Nurix Therapeutics to Participate in Upcoming Investor Conferences May 13, 2026 7:00 AM - Globe NewsWire Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress May 12, 2026 4:05 PM - Globe NewsWire Form SCHEDULE 13G Nurix Therapeutics, Inc. Filed by: FMR LLC May 6, 2026 11:30 AM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: May 05 Filed by: van Houte Hans May 5, 2026 7:54 PM - SEC Filing Form 144 Nurix Therapeutics, Inc. Filed by: van Houte Hans May 5, 2026 4:29 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: May 04 Filed by: Ring Christine May 4, 2026 6:11 PM - SEC Filing Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine May 4, 2026 4:28 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: May 01 Filed by: Ring Christine May 1, 2026 5:51 PM - SEC Filing Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine May 1, 2026 4:49 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: Apr 30 Filed by: van Houte Hans April 30, 2026 5:38 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: Apr 30 Filed by: Ring Christine April 30, 2026 5:38 PM - SEC Filing Form 4 Nurix Therapeutics, Inc. For: Apr 30 Filed by: Hansen Gwenn April 30, 2026 5:36 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Nurix (NRIX) April 27, 2026 6:48 AM - StreetInsider Form SCHEDULE 13G/A Nurix Therapeutics, Inc. Filed by: Redmile Group, LLC April 24, 2026 9:28 PM - SEC Filing Nurix presents preclinical data on protein degradation programs at AACR April 22, 2026 7:01 AM - StreetInsider Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026 April 22, 2026 7:00 AM - StreetInsider Piper Sandler Reiterates Overweight Rating on Nurix (NRIX) April 10, 2026 8:50 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Nurix (NRIX) April 10, 2026 6:46 AM - StreetInsider Nurix (NRIX) PT Raised to $27 at JPMorgan April 9, 2026 8:47 AM - StreetInsider RBC Capital on Nurix (NRIX): 'Execution in CLL Remains Key' April 9, 2026 8:34 AM - StreetInsider Nurix (NRIX) PT Lowered to $28 at Wells Fargo April 9, 2026 5:59 AM - StreetInsider BTIG Reiterates Buy Rating on Nurix (NRIX) April 9, 2026 5:00 AM - StreetInsider Oppenheimer on Nurix (NRIX): 'We think this part of the story is getting more interesting' April 8, 2026 12:32 PM - StreetInsider Nurix (NRIX) PT Lowered to $34 at Stifel April 8, 2026 12:10 PM - StreetInsider Nurix Therapeutics, Inc. (NRIX) Misses Q1 EPS by 3c April 8, 2026 7:34 AM - StreetInsider Form 10-Q Nurix Therapeutics, Inc. For: Feb 28 April 8, 2026 6:05 AM - SEC Filing Form 8-K Nurix Therapeutics, Inc. For: Apr 08 April 8, 2026 6:05 AM - SEC Filing Nurix Therapeutics reports $87.2 million Q1 loss amid drug trials April 8, 2026 6:01 AM - StreetInsider Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update April 8, 2026 6:00 AM - Globe NewsWire Nurix Therapeutics to Participate in Upcoming Investor Conference April 7, 2026 10:12 AM - Globe NewsWire Form 4 Nurix Therapeutics, Inc. For: Apr 02 Filed by: Ring Christine April 2, 2026 7:02 PM - SEC Filing Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine April 2, 2026 4:26 PM - SEC Filing Form SCHEDULE 13G/A Nurix Therapeutics, Inc. Filed by: VANGUARD GROUP INC March 27, 2026 11:09 AM - SEC Filing Form ARS Nurix Therapeutics, Inc. For: Nov 30 March 27, 2026 6:07 AM - SEC Filing Form DEFA14A Nurix Therapeutics, Inc. March 27, 2026 6:07 AM - SEC Filing Form DEF 14A Nurix Therapeutics, Inc. For: May 15 March 27, 2026 6:07 AM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Nurix (NRIX) March 24, 2026 6:40 AM - StreetInsider Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting March 23, 2026 4:05 PM - StreetInsider Full Article List